Physician

Sakher M Albadarin, M.D.

According to 2025 Medicare claims, Sakher Albadarin, M.D. (NPI: 1750670568) practices gastroenterology in the Kansas City, MO-KS market, with the plurality of this provider's patient population coming from Jackson, MO. This provider's primary affiliated billing organization is MID AMERICA GASTRO INTESTINAL CONSULTANTS P C (NPI: 1710091228; TIN: 431356738) and primary practice location at 64111-5936.

Albadarin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 777 traditional Medicare patients, billed 32,133 HCPCS/CPT codes, and received $607,529 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 1,086 prescription claims across 549 beneficiaries totaling $251,369 in drug costs, led by Zenpep (Lipase/Protease/Amylase). 2021 DME data shows 34 claims. Open Payments data shows 40 records totaling $798. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $36,619 to $251,369. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	177	1,776	$34,087
2018	349	9,832	$105,611
2019	375	25,831	$270,371
2020	545	28,884	$844,440
2021	725	45,829	$1,107,586
2022	633	22,425	$468,868
2023	733	25,168	$523,467
2024	777	32,133	$607,529

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	38	125	$36,619
2016	20	53	$6,554
2017	66	147	$13,974
2018	164	446	$53,207
2019	275	607	$93,545
2020	296	684	$115,863
2021	458	992	$306,841
2022	445	1,009	$636,695
2023	418	908	$596,804
2024	549	1,086	$251,369

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	34	$5,673
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	146	147	$198
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	146	146	$113
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	187	211	$82
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	100	103	$71
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	109	114	$61

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Zenpep	Lipase/Protease/Amylase	21	572	$98,157
Sod Sulf-Potass Sulf-Mag Sulf	Sodium, Potassium,mag Sulfates	376	558	$24,923
Creon	Lipase/Protease/Amylase	14	308	$17,013
Linzess	Linaclotide	13	750	$12,807
Dexlansoprazole Dr	Dexlansoprazole	18	1,020	$6,138

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	40	$798	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sakher M. Albadarin, M.D.?

Tedicare shows public-source Medicare data for Sakher M. Albadarin, M.D. (NPI 1750670568), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sakher M. Albadarin, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sakher M. Albadarin, M.D.?

Sakher M. Albadarin, M.D. is linked to MID AMERICA GASTRO INTESTINAL CONSULTANTS P C (billing NPI 1710091228) in the available physician profile data.

Does Sakher M. Albadarin, M.D. have Open Payments data?

Sakher M. Albadarin, M.D. has 40 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.